Clinical Trials Browser

Phase 1/2 × Terminated × Uterine Neoplasms × Clear all

Head and Neck Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Sarcoma, Uterine Neoplasms

NCT05949632 2025-08-03

A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors

Adenocarcinoma, Mucinous, Carcinosarcoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Cystadenocarcinoma, Serous

NCT04424641 2023-07-25

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Phase 1/2 Terminated

48 enrolled 20 charts

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Prostatic Neoplasms, Uterine Neoplasms, Triple Negative Breast Neoplasms

NCT00506779 2020-11-18

Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma

Phase 1/2 Terminated

17 enrolled 7 charts

Gynecologic

Uterine Neoplasms

Clinical Trials

Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors

A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma